## **Core Concept**
The question pertains to the sonological indicators used in prenatal ultrasound to suspect aneuploidy, which refers to the presence of an abnormal number of chromosomes in a cell, often leading to genetic disorders. Aneuploidy can be detected through various ultrasound markers.

## **Why the Correct Answer is Right**
The correct answer, **nuchal translucency (NT)**, is considered the most sensitive sonological indicator for aneuploidy. Nuchal translucency refers to the thickness of the fluid-filled space at the back of the fetus's neck, measured between 11 and 14 weeks of gestation. An increased NT thickness is associated with an increased risk of aneuploidy, particularly Down syndrome (Trisomy 21), as well as other chromosomal abnormalities and cardiac malformations. The measurement of NT is part of the combined first-trimester screening for aneuploidy, which also includes maternal age, fetal heart rate, and biochemical markers like free beta-hCG and PAPP-A.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain **fetal markers** can indicate an increased risk of aneuploidy, this option is too broad and nonspecific, as there are many markers, and not all are equally sensitive or specific.
- **Option B:** **Fetal nasal bone** absence or hypoplasia can be a marker for aneuploidy, particularly Down syndrome. However, it is not as sensitive as nuchal translucency because the presence or absence of the nasal bone can vary among normal fetuses, and its assessment can be technically challenging.
- **Option C:** This option is not provided, so we proceed with the understanding that **Option D** needs evaluation.
- **Option D:** Without a specific option provided for D, we focus on the rationale that makes **nuchal translucency** the most appropriate answer.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **nuchal translucency test** should be performed between 11 and 14 weeks of gestation, and a thickness of ≥3.5 mm is generally considered increased. This test, when combined with maternal serum screening, significantly enhances the detection rate for aneuploidy.

## **Correct Answer:** . nuchal translucency.